D050483Chemicals & DrugsD12.776.157.530.450.625.124D12.776.157.530.562.374.500.500D12.776.157.530.937.500D12.776.543.585.450.625.124D12.776.543.585.562.374.500.500D12.776.543.585.937.50022350.971789Dopamine Plasma Membrane Transport Proteinsprns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson30230123Schacht JP, Anton RF, McNamara PJ, Im Y, King ACAddiction biologyThe dopamine transporter VNTR polymorphism moderates the relationship between acute response to alcohol and future alcohol use disorder symptoms. Addict Biol. 2019 09; 24(5):1109-1118.Addict Biol2018-09-18T00:00:002018The dopamine transporter VNTR polymorphism moderates the relationship between acute response to alcohol and future alcohol use disorder symptoms.Psychiatry and Behavioral Neuroscience-ResearchPublic Health Sciences0.7961610.0081420322research area of0.6818380.033513632subject area forNeurologyUniversity of ChicagoChristopher M.Gomez1GVmBqQPOeLchGhrbEnp6iv47M/z/LZWeXp7ceLFF3NDChristopher M. Gomez41.78927490000000-87.601250000000001095Gomez, Christopher M.ProfessorAndrea C.King1mlgBaY1eePdkDRmc0Kg5mby9si87roQdX1vAndrea C. King41.78927490000000-87.601250000000001293King, Andrea C.ProfessorPaulVezinaPaul Vezina41.78927490000000-87.601250000000001492Vezina, PaulPROFESSORTaoXieTao Xie41.78927490000000-87.601250000000002254Xie, TaoProfessorBenjaminLaheyBenjamin Lahey41.78927490000000-87.60125000000000757Lahey, BenjaminProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1PROFESSORPROFESSORtrue1ProfessorProfessortrue1ProfessorProfessor24064458O'Brien TC, Mustanski BS, Skol A, Cook EH, Wakschlag LSNeurotoxicology and teratologyDo dopamine gene variants and prenatal smoking interactively predict youth externalizing behavior? Neurotoxicol Teratol. 2013 Nov-Dec; 40:67-73.Neurotoxicol Teratol2013-09-21T00:00:002013Do dopamine gene variants and prenatal smoking interactively predict youth externalizing behavior?Psychiatry & Behav. Neurosci27113203Wang Q, Bubula N, Brown J, Wang Y, Kondev V, Vezina PNeuroscience lettersPKC phosphorylates residues in the N-terminal of the DA transporter to regulate amphetamine-induced DA efflux. Neurosci Lett. 2016 05 27; 622:78-82.Neurosci Lett2016-04-22T00:00:002016PKC phosphorylates residues in the N-terminal of the DA transporter to regulate amphetamine-induced DA efflux.27036891Salinas AG, Davis MI, Lovinger DM, Mateo YNeuropharmacologyDopamine dynamics and cocaine sensitivity differ between striosome and matrix compartments of the striatum. Neuropharmacology. 2016 09; 108:275-83.Neuropharmacology2016-03-30T00:00:002016Dopamine dynamics and cocaine sensitivity differ between striosome and matrix compartments of the striatum.27544504Xie T, Appelbaum D, Bernard J, Padmanaban M, Pu Y, Gomez CJournal of neurologyEvaluation of parkinsonism and striatal dopamine transporter loss in patients with spinocerebellar ataxia type 6. J Neurol. 2016 Nov; 263(11):2302-2307.J Neurol2016-08-20T00:00:002016Evaluation of parkinsonism and striatal dopamine transporter loss in patients with spinocerebellar ataxia type 6.